
Join to view full profile
750 Eureka StSuite DWeatherford, TX 76086
Phone+1 817-324-0993
Fax+1 817-596-5109
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Gregory Schwartz, MD is a board certified orthopedic surgeon in Weatherford, Texas. He is currently licensed to practice medicine in Texas and South Carolina. He is affiliated with Texas Health Harris Methodist Hospital Azle.
Education & Training
Prisma Health/University of South Carolina SOM Greenville (Greenville)Residency, Orthopaedic Surgery, 1991 - 1996
University of Texas Medical Branch School of MedicineClass of 1991
Certifications & Licensure
TX State Medical License 1996 - 2028
SC State Medical License 1992 - 2019
American Board of Orthopaedic Surgery Orthopaedic Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Rcopia, DrFirst, 2013-2014, 2016
- CMS Meaningful Use Stage 1 Certification Rcopia MU, DrFirst, 2013-2014, 2016
- CMS Meaningful Use Stage 2 Certification Wellcentive Registry, Wellcentive, Inc., 2013-2014, 2016
Publications & Presentations
PubMed
- 44 citationsEffect of selective BET protein inhibitor apabetalone on cardiovascular outcomes in patients with acute coronary syndrome and diabetes: Rationale, design, and baseline...Kausik K. Ray, Stephen J. Nicholls, Henry D Ginsberg, Jan O. Johansson, Kamyar Kalantar-Zadeh
American Heart Journal. 2019-11-01 - 103 citationsEffect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical TrialPhilippe Gabriel Steg, Michael Szarek, Deepak L. Bhatt, Vera Bittner, Marie-France Bregeault
Circulation. 2019-07-09 - 131 citationsAlirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES TrialMichael Szarek, Harvey D. White, Gregory G. Schwartz, Marco Alings, Deepak L. Bhatt
Journal of the American College of Cardiology. 2019-02-05